Presentation Imagination resembles a game, and motivation frequently conceals in the most unforeseen spots. By investigating the world in

(Reuters) -Researchers monitoring the brain activity of a patient with a severe binge-eating problem reported that Eli Lilly's GLP-1 weight-loss drug appeared to temporarily suppress food-craving ​signals in the "reward center" of the brain. These are the first direct measurements of brain activity ‌in a person receiving tirzepatide, sold as Mounjaro for diabetes and Zepbound for weight loss, shedding light on the treatment's impact on so-called ‌food noise.

Flu is surging across most of the U.S. Amid an early, harsh season, the flu shot may be more effective than predicted against the H3N2 subclade K strain.